To see how drugs Atorvastatin & Atorvastatin plus Ezetimibe have effect on lipid profile in chronic kidney disease patients : A Randomised control trial
Not Applicable
- Conditions
- Health Condition 1: N189- Chronic kidney disease, unspecified
- Registration Number
- CTRI/2023/07/054891
- Lead Sponsor
- Dr Dolly Narwal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Who gives consent.
2. Patients with Chronic Kidney Disease between Age group of 40-60 years.
3. On Conservative Management for Chronic Kidney Disease.
4. As evidenced radiologically (Bilateral Shruken Kidney /Loss of corticomedullary differentiation) or biochemically (elevated blood urea, serum creatinine) for more than 3 months.
5. With known Chronic Kidney Disease irrespective of the etiology.
Exclusion Criteria
1. Patients with Acute renal failure and Nephrotic syndrome.
2. Patients on drugs affecting Lipid metabolism like Beta Blockers, steroids and Oral contraceptive pills.
3. Female patients who are pregnant.
4. Known Hypothyroidism patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effect of drug atorvastatin and atorvastatin plus ezetimibe on lipid profile in chronic kidney disease patients.Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method To monitor the differences between the two regimens with respect to effect size profile within follow up period.Timepoint: 4 weeks